Catalog4 refs
Cartalax (AED peptide)
Healing & RecoveryResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Body Map
JointsSkin
Overview
Synthetic tripeptide developed by Professor Vladimir Khavinson, supporting cartilage, connective tissue, and cellular regeneration through proliferation markers and apoptosis pathway modulation. Modulates cell proliferation, suppresses apoptosis, affects fibroblast activity, reduces senescence markers, and influences extracellular matrix preservation.
Primary Uses
Joint and connective tissue support
Anti-aging effects on fibroblasts
Cartilage regeneration support
Osteoarthritis treatment
Osteochondrosis treatment
Osteoporosis treatment
Degenerative joint disease prevention
Post-fracture recovery
Fibroblast activation
Collagen production enhancement
Cellular senescence reduction
Protocol Reference
Dose
100-200mcg oral (1-2 capsules) or 700-1400mcg injectable
Frequency
1-2 times daily with meals (oral) or once daily (injectable)
Half-life
Minutes (short peptide); effects persist via epigenetic changes
Route
oral · injectable · topical
Evidence
Emerging
Research Models
Human
Also in Healing & Recovery